Dynavax Technologies Corporation (DVAX) Financials
Stock symbol DVAX is outdated, potentially delisted? Maybe it is available on other exchange?
DVAX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2025 | 946.5 million | 412.4 million |
| June 30, 2025 | 918.4 million | 424.3 million |
| March 31, 2025 | 945.9 million | 415.0 million |
| Dec. 31, 2024 | 986.3 million | 389.5 million |
DVAX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2025 | 32.6 million | 12.4 million |
| June 30, 2025 | 22.0 million | 13.0 million |
| March 31, 2025 | -23.6 million | 14.5 million |
| Dec. 31, 2024 | 49.5 million | 13.0 million |
DVAX Net Income
No data available :(
DVAX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2025 | 647.8 million | 245.0 million | 24.0 million |
| June 30, 2025 | 613.7 million | 245.5 million | 24.7 million |
| March 31, 2025 | 661.3 million | 286.0 million | 25.5 million |
| Dec. 31, 2024 | 713.8 million | 250.2 million | 30.6 million |
DVAX Shares Outstanding
DVAX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2025 | 1.2 million | 19.1 million | 40.1 million | - |
| June 30, 2025 | 1.5 million | 16.6 million | 50.4 million | - |
| March 31, 2025 | 3.9 million | 19.4 million | 47.7 million | - |
| Dec. 31, 2024 | 3.5 million | 18.7 million | 41.6 million | - |
DVAX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2025 | 94.9 million | 14.4 million |
| June 30, 2025 | 95.4 million | 14.0 million |
| March 31, 2025 | 68.2 million | 13.8 million |
| Dec. 31, 2024 | 72.0 million | 13.4 million |
DVAX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
DVAX
Price: $15.50
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.5 million
Ebitda: -21.6 millionMarket Capitalization: 1.8 billion